Concomitant immunity
Concomitant immunity is the phenomenon where an individual with a persistent infection displays immunity to re-infections caused by similar pathogens. In other words, the persistence of the primary infection prevents the occurrence of secondary infections. The presence of concomitant immunity depends on the nature of the immune response caused by a latent infection and hence differs from pathogen to pathogen.[1] The concept was originally developed in tumor immunology, where a mouse with a tumor graft does not allow a second tumor graft of the same type to develop. It has also been called premunition, nonsterilizing immunity,[2] and infection-immunity.[1] Being dependent on an existing infection, it is a type of acquired immunity.
| Pathogen | Mechanism |
|---|---|
| Lymphocytic choriomeningitis virus | "relatively long-lived" effector-like memory T cells at nonlymphoid sites[1] |
| Leishmania major | "relatively short-lived" CD4+ regulatory T cells and CD4+ effector T cells[1] |
| Onchocerca volvulus | Unclear, known to occur based on cytokine and antibody evidence[3] |
| Schistosoma | Unclear, proposed to display concomitant immunity[4] |
| Mycobacterium tuberculosis | tissue-resident Memory T cells with an estimated lifespan of 2–3 years[1] |
References
- ^ a b c d e Joslyn, Louis R.; Flynn, JoAnne L.; Kirschner, Denise E.; Linderman, Jennifer J. (1 December 2022). "Concomitant immunity to M. tuberculosis infection". Scientific Reports. 12 (1): 20731. Bibcode:2022NatSR..1220731J. doi:10.1038/s41598-022-24516-8. PMC 9713124. PMID 36456599.
- ^ Mitchell, Graham F. (1990). "A Note on Concomitant Immunity in Host-Parasite Relationships: A Successfully Transplanted Concept from Tumor Immunology". Advances in Cancer Research. 54: 319–332. doi:10.1016/S0065-230X(08)60816-7. ISBN 978-0-12-006654-4. PMID 2105004.
- ^ MacDonald, Angus J.; Turaga, Prasad S. D.; Harmon-Brown, Carolyn; Tierney, Tracy J.; Bennett, Kristine E.; McCarthy, Maggie C.; Simonek, Scott C.; Enyong, Peter A.; Moukatte, Daniel W.; Lustigman, Sara (June 2002). "Differential Cytokine and Antibody Responses to Adult and Larval Stages of Onchocerca volvulus Consistent with the Development of Concomitant Immunity". Infection and Immunity. 70 (6): 2796–2804. doi:10.1128/iai.70.6.2796-2804.2002. PMC 127981. PMID 12010965.
- ^ Buck, Julia C.; De Leo, Giulio A.; Sokolow, Susanne H. (25 February 2020). "Concomitant Immunity and Worm Senescence May Drive Schistosomiasis Epidemiological Patterns: An Eco-Evolutionary Perspective". Frontiers in Immunology. 11. doi:10.3389/fimmu.2020.00160. PMC 7053360.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.